Antibiotic tested to help patients breathe easier during lung crisis
NCT ID NCT05842681
Summary
This study is testing if adding the antibiotic azithromycin to standard hospital treatment helps adults with a sudden, severe flare-up of a lung-scarring disease called IPF. Researchers want to see if the add-on drug shortens hospital stays and improves breathing. The trial will also help doctors understand which patients might benefit most from this approach.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Assiut university-Faculty of Medicine
RECRUITINGAsyut, 71515, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Faculty of Medicine Assuit University
ACTIVE_NOT_RECRUITINGAsyut, Egypt
Conditions
Explore the condition pages connected to this study.